170 related articles for article (PubMed ID: 11847572)
1. Hepatocellular carcinoma: harmonic ultrasound and contrast agent.
Kim TK; Kim AY; Choi BI
Abdom Imaging; 2002; 27(2):129-38. PubMed ID: 11847572
[No Abstract] [Full Text] [Related]
2. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
Jung EM; Clevert DA; Rupp N
Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
[TBL] [Abstract][Full Text] [Related]
3. [Three dimensional ultrasound diagnosis of hepatocellular carcinoma].
Tochio H; Okabe Y; Kudo M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():265-8. PubMed ID: 11761952
[No Abstract] [Full Text] [Related]
4. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.
Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ
Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584
[TBL] [Abstract][Full Text] [Related]
5. Quantitative comparison of tumor vascularity of hepatocellular carcinoma after intravenous contrast agent: conventional versus harmonic power Doppler US.
Park SH; Kim TK; Lee KH; Kim AY; Choi JI; Han JK; Choi BI
Abdom Imaging; 2001; 26(2):178-83. PubMed ID: 11178696
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
Radiology; 2001 Aug; 220(2):349-56. PubMed ID: 11477236
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional power Doppler imaging in depicting vascularity in hepatocellular carcinoma.
Xu HX; Liu L; Lu MD; Li HP; Liu GJ; Li JP
J Ultrasound Med; 2003 Nov; 22(11):1147-54. PubMed ID: 14620884
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
[TBL] [Abstract][Full Text] [Related]
9. [Contrast enhanced power Doppler in evaluating the angiogenesis in hepatocellular carcinoma].
Xiao JD; Shen SR; Li RZ; Zhou P; Zhu WH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):840-4. PubMed ID: 18007081
[TBL] [Abstract][Full Text] [Related]
10. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonograpy.
Suzuki Y; Fujimoto Y; Hosoki Y; Suzuki M; Sakurai S; Ohhira M; Saito H; Kohgo Y
Eur J Radiol; 2003 Nov; 48(2):214-9. PubMed ID: 14680917
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of hepatocellular carcinoma using digital subtraction imaging with the contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiography.
Yamamoto K; Shiraki K; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Hashimoto A; Shimizu A; Okuda Y; Nakano T
Oncol Rep; 2002; 9(4):789-92. PubMed ID: 12066210
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous ultrasound contrast agent, Levovist].
Kudo M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():306-13. PubMed ID: 11761963
[No Abstract] [Full Text] [Related]
14. Assessment of vascular patterns of small liver mass lesions: value and limitation of the different Doppler ultrasound modalities.
Gaiani S; Casali A; Serra C; Piscaglia F; Gramantieri L; Volpe L; Siringo S; Bolondi L
Am J Gastroenterol; 2000 Dec; 95(12):3537-46. PubMed ID: 11151890
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography of hepatocellular carcinoma.
Brizi MG; De Franco A; Vecchioli A
Rays; 1990; 15(3):337-51. PubMed ID: 1963229
[No Abstract] [Full Text] [Related]
16. Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced power Doppler sonography and contrast-enhanced harmonic imaging.
Esteban JM; Gil J
Acad Radiol; 2002 Aug; 9 Suppl 2():S382-3. PubMed ID: 12188283
[No Abstract] [Full Text] [Related]
17. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging.
Wilson SR; Burns PN
Semin Liver Dis; 2001 May; 21(2):147-59. PubMed ID: 11436569
[TBL] [Abstract][Full Text] [Related]
18. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US.
Lencioni R; Pinto F; Armillotta N; Bartolozzi C
Radiology; 1996 Nov; 201(2):353-8. PubMed ID: 8888222
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
[TBL] [Abstract][Full Text] [Related]
20. [Imaging tumor vascularization of hepatocellular carcinoma with ultrasound angiography].
Becker D; Günter E; Hahn EG; Heyder N
Ultraschall Med; 1995 Jun; 16(3):109-12. PubMed ID: 7667617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
